Journals / Retina-Vitreus / 2009 / Cilt: 17 - Sayı: 1

Retinal nerve fibre layer thickness in patients using antimalarial drugs

Antimalaryal ilaç kullanan hastalarda retina sinir lifi kalınlığının değerlendirilmesi

Pages
37–41
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: The RNFL thickness measured with both OCT and HRT didn’t change in patients that were on antimalarial drugs therapy during the study course.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: To evaluate the retina nerve fibre layer (RNFL) thickness with Heidelberg retinal topography (HRT) and optic coherence tomography (OCT) in patients who were use antimalarial drugs Materials and Methods: This case-control study included 92 eyes of 46 patients that were on systemic hydroxychloroquine and chloroquine therapy for systemic lupus erythematosus(n=18), discoid lupus erythematosus (n=5), rheumatoid arthritis (n=8), Sjögren’s syndrom (n=9) and connective tissue disorders (n=6).
📊
Key Findings & Data:The control group was comprised of 25 female and seven male.
💡
Conclusion & Impact:Conclusion: The RNFL thickness measured with both OCT and HRT didn’t change in patients that were on antimalarial drugs therapy during the study course.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Antimalaryaller · Retina · Tomografi

Abstract

Purpose: To evaluate the retina nerve fibre layer (RNFL) thickness with Heidelberg retinal topography (HRT) and optic coherence tomography (OCT) in patients who were use antimalarial drugs Materials and Methods: This case-control study included 92 eyes of 46 patients that were on systemic hydroxychloroquine and chloroquine therapy for systemic lupus erythematosus(n=18), discoid lupus erythematosus (n=5), rheumatoid arthritis (n=8), Sjögren’s syndrom (n=9) and connective tissue disorders (n=6). The control group was comprised of 25 female and seven male. Peripapillary RNFL measurements obtained with HRT and OCT were compared between two groups. Results: Mean age of patient and control groups were 46.8±14.9 and 51.4±9.3 years respectively. RNFL thickness measurement in the patient’s group with HRT at the onset, sixth and 12 th month for the right eye was 0.26±0.06, 0.27±0.05, 0.27±0.05 mm and for the left eye it was 0.27±0.07, 0.28±0.06, 0.26±0.06 mm respectively. RNFL thickness with HRT in the control group for the right and left eye was 0.27±0.09 and 0.25±0.05 mm respectively. Average RNFL thickness measurement in the patient’s group with OCT at the onset, sixth and 12 th month for the right eye was 105.3±12.3, 104.5±11.08, 100.6 ±11.5 µm and for the left eye was 104.8±12.2, 103.9±13.17, 100.0±8.9 µm respectively. In the control group for the right eye and the left eye was 99.5 ±11.5 and 97.12±11.3 µm respectively. Conclusion: The RNFL thickness measured with both OCT and HRT didn’t change in patients that were on antimalarial drugs therapy during the study course.

Özet

Amaç: Antimalaryal ilaç kullanan hastalarda Heidelberg retinal tomografi (HRT) ve optik koherens tomografi (OKT) ile retina sinir lifi tabakası (RSLT) kalınlığının değerlendirilmesi Gereç ve Yöntem: Vaka kontrol şeklinde olan bu çalışmada sistemik lupus eritematozus (n=18), diskoid lupus eritematozus (n=5), romatoid artrit (n=8), Sjögren sendromu (n=9) ve bağ dokusu hastalığı (n=6) nedeni ile hidroksiklorokin veya klorokin kullanan 46 hastanın 92 gözü alındı. Kontrol grubu 25 bayan ve 7 erkek içermekteydi. OKT ve HRT ile ölçülen peripapiller RSLT kalınlığı iki grup arasında karşılaştırıldı. Bulgular: Hastaların ve kontrol grubunun ortalama yaşı sırası ile 46.8±14.9 ve 51.4±9.3 yıldı. Hastaların HRT ile RSLT kalınlıkları başlangıçta, 6. ve 12. ayda sağ göz için 0.26±0.06 mm, 0.27±0.05 mm ve 0.27±0.05 mm, sol göz için 0.27±0.07 mm, 0.28±0.06 mm ve 0.26±0.06 mm idi. Kontrol grubunun HRT ile RSLT kalınlıkları sağ ve sol göz için 0.27±0.09 mm ve 0.25±0.05 mm idi. Hastaların OKT ile ortalama RSLT kalınlığı başlangıçta, altıncı ve 12. ayda sağ göz için 105.3±12.3 µm, 104.5±11.0 µm ve 100.6±11.5 µm; sol göz için 104.8±12.2 µm, 103.9±13.1 µm ve 100.0±8.9 µm idi. Kontrol grubunun OKT ile ortlama RSLT kalınlığı sağ ve sol göz için 99.5±11.5 µm ve 97.1±11.3 µm idi Sonuç: Sistemik hastalıklara bağlı antimalaryal ilaç kullanan hastalarda hem HRT hem de OKT ile RSLT kalınlığında takip süresince incelme tespit edilmedi.

🔖

Cite This Article

YILMAZ, O., SAATVİ, A. O. (2009). Retinal nerve fibre layer thickness in patients using antimalarial drugs. Retina-Vitreus, Cilt: 17 - Sayı: 1, 37–41. https://ajindex.com/articles/305172

References (15)

  1. Rynes RI.: Antimalarial drugs in the treatment of rheumatological diseases. Br J Rheumatol. 1997;36:799-805
  2. Cambiaggi A.: Unusual ocular lesions in a case of systemic lupus erythematosis. Arch Ophthalmol. 1957;57:451-453
  3. Easterbrook M.: Detection and prevention of maculopathy associated with antimalarial agents. Int Ophthalmol Clin. 1999;39: 49-57
  4. Neubauer AS, Stiefelmeyer S, Berninger T, et al.: The multifocal pattern electroretinogram in chloroquine retinopathy. Ophthalmic Res. 2004;36:106-113
  5. İzgi B, Manav G, Urgancıoğlu M.: Klorokin retinopatisi ve erken tanısında bilgisayarlı görme alanın yeri. T Oft Gaz. 1993; 23:122-125
  6. Easterbrook M.: Current concepts in monitoring patients on antimalarials. Aust NZ Ophthalmol. 1998;26:101-103
  7. Easterbrook M.: Long-term course of antimalarial maculapathy after cessation of treatment. Can J Ophthalmol. 1992;27:237-239
  8. Kellner U, Kraus H, Foerster MH.: Multifocal ERG in chloroquine retinopathy. Graefes Arch Clin Exp Ophthalmol. 2000;238: 94-97
  9. Maturi RK, Yu M, Weleber RG.: Multifocal electroretinographic evalation of long-term hydroxycholoroquine users Arch Ophthalmol. 2004;122:973-981
  10. Lai TTY, Chan WM, Li H, et al.: Multifocal electroretinographic changes in patients receiving hydroxycholoroquine retinopathy. Am J Ophthalmol. 2005;140:794-807
  11. Kellner U, Kraus H, Foerster MH.: Multifocal ERG in chloroquine retinopathy: Regional variance of retinal dysfunction. Graefes Arch Clin Exp Ophthalmol. 2000;238:94-97
  12. Tzekov RT, Serrato A, Marmor MF.: ERG findings in patients using hydroxychloroquine. Doc Ophthalmol. 2004;108:87-97
  13. Bonanomi MT, Dantas NC, Medeiros FA.: Retinal nerve layer thickness measurement in patients using chloroquine. Clin Exp Ophthalmol. 2006;34:130-136
  14. Rodriguez-Padilla JA, Hedges TR, Monson B, et al.: Highspeed ultra-high-resolution optical coherence tomogragphy findings in hydroxychloroquine retinopathy Arch Ophthalmol. 2007;125:775-780
  15. Fontaine F, Rougier MB, Korobelnik JF.: Optical coherence tomography in hydroxycholoroquine retinopathy: Two observational case reports. Retinal Cases&Brief Reports. 2007;1:131.